The Hidden Toll of Cancer Treatment: A Survivor’s Story

Cancer survival is often celebrated as a definitive victory, but for many patients, the end of active treatment marks the beginning of a complex struggle with long-term health complications. These “hidden tolls” range from premature endocrine failure to chronic cardiovascular and neurological comorbidities, highlighting a critical need for specialized survivorship care.

Recent reports and research emphasize that the treatments used to save lives can induce accelerated aging and permanent physiological changes. For some survivors, this manifests as early menopause; for others, it involves the development of secondary malignancies or chronic systemic illnesses decades after the initial diagnosis.

The Impact of Long-Term Survival and Accelerated Aging

The University of Cincinnati Cancer Center has highlighted the phenomenon of accelerated aging in childhood cancer survivors. Alique Topalian, a research scientist who was treated for acute myeloid leukemia at age 4, has documented the persistent health challenges that follow long-term survival.

Topalian’s personal medical history includes immunoglobulin deficiency, which impairs the ability to fight infections, as well as learning disabilities, high blood pressure, and fainting spells. She has also reported a persistent fever of 100.4 degrees for which her care team has found no explanation.

These experiences underscore the myriad late-term side effects that can emerge long after the primary cancer has been treated. This gap in care is a primary focus of research presented at the 2025 American Society of Clinical Oncology Annual Meeting, which advocated for the importance of specialized care for survivors.

Cardiovascular and Systemic Comorbidities

The physical toll of cancer treatment often extends to the heart and endocrine system. The field of cardiooncology has emerged specifically to address the care of the heart in cancer survivors, acknowledging that the treatments used to eliminate tumors can cause significant cardiac damage.

Data from the University of Cincinnati’s oncology primary care clinic reveals the prevalence of these issues among adolescent and young adult cancer survivors. According to research conducted by Topalian, among patients seen at the clinic:

• 60% were diagnosed with a cardiovascular disease, such as hypertension.
• 14% were diagnosed with a second primary malignancy.
• Neurologic, endocrine, and psychological comorbidities were also found to be common.

Beyond cardiovascular health, some survivors face sudden endocrine shifts. For example, Laura Ryan, a mother from Toowoomba, shared her experience of entering early menopause at age 43 as a direct result of the treatment that saved her life.

The Role of Oncology Primary Care

The complexity of these late-term effects suggests that standard primary care may not be sufficient for long-term survivors. Because many survivors are unaware of the potential side effects that may emerge decades post-treatment, specialized oncology primary care is becoming essential.

When we’re living decades posttreatment, we need providers who know how to handle [what] might happen. A lot of us don’t even know what might happen,

Alique Topalian, PhD, research scientist in the Department of Family and Community Medicine’s Division of Survivorship and Supportive Services in UC’s College of Medicine

This specialized approach aims to bridge the gap between acute cancer treatment and lifelong health management, ensuring that comorbidities like hypertension or endocrine failure are identified and managed proactively.

Financial and Psychosocial Dimensions

The toll of survival is not exclusively medical. In Britain, a report has revealed a significant financial burden associated with surviving breast cancer, estimating a hidden cost of £12,000 per year.

the psychological impact and the need for supportive wellness services continue to be a priority for survivor communities. Initiatives such as DEMIblue Cares in St. Louis have focused on providing healthy nail care specifically for cancer survivors, addressing the physical damage caused by treatment to improve overall well-being.